These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20137351)

  • 1. [Value of high-field MR diffusion-weighted MR imaging in the diagnosis of endometrial carcinoma].
    Wang LX; Zhou CW; Ouyang H
    Zhonghua Zhong Liu Za Zhi; 2009 Nov; 31(11):849-53. PubMed ID: 20137351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of the apparent diffusion coefficient in differentiating stage IA endometrial carcinoma from normal endometrium and benign diseases of the endometrium: initial study at 3-T magnetic resonance scanner.
    Wang J; Yu T; Bai R; Sun H; Zhao X; Li Y
    J Comput Assist Tomogr; 2010; 34(3):332-7. PubMed ID: 20498531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for distinguishing low-grade endometrioid and serous carcinomas of endometrium.
    Garg K; Soslow RA
    Adv Anat Pathol; 2012 Jan; 19(1):1-10. PubMed ID: 22156830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative diffusion-weighted magnetic resonance imaging of normal and diseased uterine zones.
    Kilickesmez O; Bayramoglu S; Inci E; Cimilli T; Kayhan A
    Acta Radiol; 2009 Apr; 50(3):340-7. PubMed ID: 19235579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body diffusion-weighted MR imaging of uterine endometrial cancer: is it helpful in the detection of cancer in nonenhanced MR imaging?
    Inada Y; Matsuki M; Nakai G; Tatsugami F; Tanikake M; Narabayashi I; Yamada T; Tsuji M
    Eur J Radiol; 2009 Apr; 70(1):122-7. PubMed ID: 18182265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IMP2 expression distinguishes endometrioid from serous endometrial adenocarcinomas.
    Zhang L; Liu Y; Hao S; Woda BA; Lu D
    Am J Surg Pathol; 2011 Jun; 35(6):868-72. PubMed ID: 21566514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion-weighted MR imaging of uterine endometrial cancer.
    Tamai K; Koyama T; Saga T; Umeoka S; Mikami Y; Fujii S; Togashi K
    J Magn Reson Imaging; 2007 Sep; 26(3):682-7. PubMed ID: 17729360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion weighted MR imaging (DWI) and ADC values in endometrial carcinoma.
    Masroor I; Zeeshan M; Afzal S; Ahmad N; Shafqat G
    J Coll Physicians Surg Pak; 2010 Nov; 20(11):709-13. PubMed ID: 21078241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion-weighted magnetic resonance imaging of endometrial cancer: differentiation from benign endometrial lesions and preoperative assessment of myometrial invasion.
    Takeuchi M; Matsuzaki K; Nishitani H
    Acta Radiol; 2009 Oct; 50(8):947-53. PubMed ID: 19724949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Histologic diagnosis of endometrial cancer].
    Kaku T; Kawano Y; Hagiwara T
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():309-12. PubMed ID: 15535257
    [No Abstract]   [Full Text] [Related]  

  • 11. Magnetic resonance imaging of endometrial cancer and clear cell cancer.
    Manabe T; Hirose Y; Kiryuu T; Koudo H; Hoshi H
    J Comput Assist Tomogr; 2007; 31(2):229-35. PubMed ID: 17414759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type.
    Clarke BA; Gilks CB
    J Clin Pathol; 2010 May; 63(5):410-5. PubMed ID: 20418232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cDNA microarray analysis and immunohistochemistry reveal a distinct molecular phenotype in serous endometrial cancer compared to endometrioid endometrial cancer.
    Chen Y; Yao Y; Zhang L; Li X; Wang Y; Zhao L; Wang J; Wang G; Shen D; Wei L; Zhao J
    Exp Mol Pathol; 2011 Aug; 91(1):373-84. PubMed ID: 21540026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed endometrioid and serous carcinoma developing in abdominal wall endometriosis following Cesarean section.
    Da Ines D; Bourdel N; Charpy C; Montoriol PF; Petitcolin V; Canis M; Garcier JM
    Acta Radiol; 2011 Jun; 52(5):587-90. PubMed ID: 21498283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrium-myometrium ratio: a newly proposed diagnostic parameter on magnetic resonance imaging assessment of myometrial invasion by endometrial cancer.
    Tang X; Muramatsu Y; Yajima M; Sonoda T
    Jpn J Clin Oncol; 1993 Oct; 23(5):278-83. PubMed ID: 8230752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
    Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
    Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Claudin 1 differentiates endometrioid and serous papillary endometrial adenocarcinoma.
    Sobel G; Németh J; Kiss A; Lotz G; Szabó I; Udvarhelyi N; Schaff Z; Páska C
    Gynecol Oncol; 2006 Nov; 103(2):591-8. PubMed ID: 16797678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serous carcinoma arising from adenomyosis.
    Liu CH; Chang WH; Liu WM; Wang PH
    Taiwan J Obstet Gynecol; 2017 Oct; 56(5):706-707. PubMed ID: 29037565
    [No Abstract]   [Full Text] [Related]  

  • 19. CD10 immunostaining distinguishes atypical polypoid adenomyofibroma (atypical polypoid adenomyoma) from endometrial carcinoma invading the myometrium.
    Ohishi Y; Kaku T; Kobayashi H; Aishima S; Umekita Y; Wake N; Tsuneyoshi M
    Hum Pathol; 2008 Oct; 39(10):1446-53. PubMed ID: 18619643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of immunohistochemistry in differential diagnosis of endometrial carcinoma].
    Wu HW; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):784-8. PubMed ID: 23302346
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.